Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
9/18/2008
 
First Published:
11/6/2007
1.
Phase III Partially Randomized Study of Risk-Directed Therapy Comprising a Modified P9407 Chemotherapy Backbone With or Without Lestaurtinib in Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Biomarker/Laboratory analysis, Treatment
Active
Under 1 at diagnosis
NCI
COG-AALL0631
AALL0631, NCT00557193
Last Modified:
8/25/2008
 
First Published:
5/1/2007
2.
Phase I/II Pilot Study of Lestaurtinib, Cytarabine, and Idarubicin in Younger Patients With Relapsed or Refractory FLT3-Mutant Acute Myeloid Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
1 to 30
NCI
COG-AAML06P1
AAML06P1, NCT00469859
3.
Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Pharmaceutical / Industry
C701a/204/ON/US
NCT00079482
4.
CEP-701 for PH-Negative Myelofibrosis
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
2007-0070
CS-2007-20040, NCT00494585
Last Modified:
10/2/2007
 
First Published:
5/28/2004
5.
Phase I Study of CEP-701 in Pediatric Patients With Recurrent or Refractory High-Risk Neuroblastoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
21 and under at diagnosis
NCI
NANT-2001-03
NCT00084422
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute